Haojian Dong
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Haojian Dong has a total of 235 co-authors. Here are the top co-authors by number of shared publications:
Xiangming Hu
31 shared publicationsYingling Zhou
Department of Cardiology, Guangdong Provincial People’s Hospital (Guangdong Academy of Medical Sciences), Southern Medical University, Guangzhou, China
27 shared publicationsBingyan Yu
Department of Cardiology, Guangdong Provincial People's Hospital (Guangdong Academy of Medical Sciences), Southern Medical University, Guangzhou 510080, China
14 shared publicationsGuang Li
Guangdong Cardiovascular Institute, Guangdong Provincial People’s Hospital (Guangdong Academy of Medical Sciences), Southern Medical University, Guangzhou, China
12 shared publicationsXing Yang
Department of Cardiology, Guangdong Provincial People's Hospital Zhuhai Hospital (Zhuhai Golden Bay Center Hospital), Zhuhai, China
12 shared publicationsDemou Luo
Guangdong Cardiovascular Institute, Guangdong Provincial People's Hospital, Guangdong Academy of Medical Sciences, No.106, Zhongshan Second Road, Yuexiu District, Guangzhou, Guangdong, 510080, China
10 shared publications
Latest Publications
- Open Access
- 12 June 2026
- Published by Springer Nature in BMC Cardiovascular Disorders
- Vol. 26 (1)
The combined effect of arterial hypertension and coronary microvascular dysfunction in the prognosis of patients with ST-segment elevation myocardial infarction: a real-world study
Despite successful primary percutaneous coronary intervention (PPCI), a substantial proportion of patients with ST-segment elevation myocardial infarction (STEMI) still develop coronary microvascular dysfunction (CMD), which is closely associated with adverse outcomes. Arterial hypertension (AH) was also associated with adverse outcomes in patients with STEMI. However, the combined prognostic value of AH and CMD in patients with STEMI remains unclear. This study aimed to assess the combined impact of AH and CMD on prognosis in patients with STEMI using the coronary angiography-derived index of microcirculatory resistance (angio-IMR). In this retrospective, two-center study, 910 patients with STEMI who underwent primary percutaneous coronary intervention (PPCI) were enrolled from July 2019 to August 2023. The follow-up endpoint was major adverse cardiovascular event (MACE), defined as all-cause mortality, non-fatal myocardial infarction, ischaemia-driven target vessel revascularisation (TVR), and new-onset heart failure. Kaplan-Meier analysis and Cox proportional hazards models were used to evaluate the associations of AH and coronary microvascular dysfunction with MACE. A restricted cubic spline plot was used to explore the nonlinear relationship between angio-IMR and MACE. Receiver operating characteristic curves were plotted to compare their predictive performance. Net weight classification index (NRI) and comprehensive discriminant improvement index (IDI) were used to evaluate the incremental predictive value. Patients with AH exhibited a higher 1-year incidence of MACE compared with non-AH patients (17.4% vs. 10.1%, P < 0.001). Among STEMI patients, those with concomitant CMD and AH showed the highest cumulative incidence of MACE (22.7%, P < 0.001). After adjusting for confounding factors, the coexistence of AH and CMD emerged as the strongest predictor of MACE among STEMI patients (hazard ratio [HR]: 3.79, 95% confidence interval [CI]: 2.009-7.146, P < 0.001). The combined model of AH and CMD demonstrated superior predictive performance compared with models including AH alone (AUC: 0.682, 95% CI: 0.675-0.689) or CMD alone (AUC: 0.703, 95% CI: 0.697-0.709), yielding the highest diagnostic efficacy (AUC: 0.713, 95% CI: 0.707-0.719). The joint model showed significant improvements in discrimination (C statistic increased from 0.699 to 0.736, P < 0.001) and reclassification (NRI = 0.142, IDI = 0.024, both P < 0.05). In STEMI patients undergoing PPCI, AH combined with CMD is closely associated with a higher risk of MACE and it helps to improve the risk stratification of these patients.
- 12 June 2026
- Published by Springer Nature in BMC Cardiovascular Disorders
- Vol. 26 (1)
Open AccessThe combined effect of arterial hypertension and coronary microvascular dysfunction in the prognosis of patients with ST-segment elevation myocardial infarction: a real-world study
Despite successful primary percutaneous coronary intervention (PPCI), a substantial proportion of patients with ST-segment elevation myocardial infarction (STEMI) still develop coronary microvascular dysfunction (CMD), which is closely associated with adverse outcomes. Arterial hypertension (AH) was also associated with adverse outcomes in patients with STEMI. However, the combined prognostic value of AH and CMD in patients with STEMI remains unclear. This study aimed to assess the combined impact of AH and CMD on prognosis in patients with STEMI using the coronary angiography-derived index of microcirculatory resistance (angio-IMR). In this retrospective, two-center study, 910 patients with STEMI who underwent primary percutaneous coronary intervention (PPCI) were enrolled from July 2019 to August 2023. The follow-up endpoint was major adverse cardiovascular event (MACE), defined as all-cause mortality, non-fatal myocardial infarction, ischaemia-driven target vessel revascularisation (TVR), and new-onset heart failure. Kaplan-Meier analysis and Cox proportional hazards models were used to evaluate the associations of AH and coronary microvascular dysfunction with MACE. A restricted cubic spline plot was used to explore the nonlinear relationship between angio-IMR and MACE. Receiver operating characteristic curves were plotted to compare their predictive performance. Net weight classification index (NRI) and comprehensive discriminant improvement index (IDI) were used to evaluate the incremental predictive value. Patients with AH exhibited a higher 1-year incidence of MACE compared with non-AH patients (17.4% vs. 10.1%, P < 0.001). Among STEMI patients, those with concomitant CMD and AH showed the highest cumulative incidence of MACE (22.7%, P < 0.001). After adjusting for confounding factors, the coexistence of AH and CMD emerged as the strongest predictor of MACE among STEMI patients (hazard ratio [HR]: 3.79, 95% confidence interval [CI]: 2.009-7.146, P < 0.001). The combined model of AH and CMD demonstrated superior predictive performance compared with models including AH alone (AUC: 0.682, 95% CI: 0.675-0.689) or CMD alone (AUC: 0.703, 95% CI: 0.697-0.709), yielding the highest diagnostic efficacy (AUC: 0.713, 95% CI: 0.707-0.719). The joint model showed significant improvements in discrimination (C statistic increased from 0.699 to 0.736, P < 0.001) and reclassification (NRI = 0.142, IDI = 0.024, both P < 0.05). In STEMI patients undergoing PPCI, AH combined with CMD is closely associated with a higher risk of MACE and it helps to improve the risk stratification of these patients.
- Open Access
- 12 February 2026
- Published by Elsevier in SSRN Electronic Journal
Predictive Value of Combined Angiography-Derived Microvascular Resistance and Left Ventricular Ejection Fraction for Outcomes in STEMI Patients Undergoing Primary PCI
Purpose: Left ventricular ejection fraction (LVEF) remains the primary risk marker post-STEMI but is insensitive to coronary microvascular dysfunction. This study evaluated whether combining angiography-derived microvascular resistance (AMR) with LVEF improves risk stratification for 12-month major adverse cardiovascular events (MACE) in STEMI patients undergoing primary percutaneous coronary intervention (PPCI).Methods: In this dual-center retrospective cohort study, 910 STEMI patients treated with PPCI were enrolled. Patients were stratified into four groups based on AMR (high: ≥250 mmHg·s/m) and LVEF (preserved: ≥50%) . Multivariable Cox proportional hazards models and ten-fold cross-validation were used to evaluate prognostic performance and discriminative ability .Results: During 12-month follow-up, 125 patients (13.7%) experienced MACE . The combined high AMR + low LVEF group exhibited the highest risk (adjusted hazard ratio: 3.22; 95% CI: 1.83–5.67). Notably, patients with isolated microvascular dysfunction (high AMR + preserved LVEF) faced a MACE hazard (14.3%) nearly identical to those with isolated systolic impairment (low AMR + low LVEF, 14.7%). The integrated AMR–LVEF model demonstrated superior discrimination (validation AUC: 0.644) compared with AMR alone (0.597) or LVEF alone (0.591).Conclusion: Combining AMR and LVEF substantially refines 1-year prognostic risk stratification in STEMI patients. This approach uncovers a critical “pathophysiological decoupling” where isolated microvascular injury confers a hazard comparable to systolic impairment, supporting the transition toward more individualized post-STEMI management .
- 12 February 2026
- Published by Elsevier in SSRN Electronic Journal
Open AccessPredictive Value of Combined Angiography-Derived Microvascular Resistance and Left Ventricular Ejection Fraction for Outcomes in STEMI Patients Undergoing Primary PCI
Purpose: Left ventricular ejection fraction (LVEF) remains the primary risk marker post-STEMI but is insensitive to coronary microvascular dysfunction. This study evaluated whether combining angiography-derived microvascular resistance (AMR) with LVEF improves risk stratification for 12-month major adverse cardiovascular events (MACE) in STEMI patients undergoing primary percutaneous coronary intervention (PPCI).Methods: In this dual-center retrospective cohort study, 910 STEMI patients treated with PPCI were enrolled. Patients were stratified into four groups based on AMR (high: ≥250 mmHg·s/m) and LVEF (preserved: ≥50%) . Multivariable Cox proportional hazards models and ten-fold cross-validation were used to evaluate prognostic performance and discriminative ability .Results: During 12-month follow-up, 125 patients (13.7%) experienced MACE . The combined high AMR + low LVEF group exhibited the highest risk (adjusted hazard ratio: 3.22; 95% CI: 1.83–5.67). Notably, patients with isolated microvascular dysfunction (high AMR + preserved LVEF) faced a MACE hazard (14.3%) nearly identical to those with isolated systolic impairment (low AMR + low LVEF, 14.7%). The integrated AMR–LVEF model demonstrated superior discrimination (validation AUC: 0.644) compared with AMR alone (0.597) or LVEF alone (0.591).Conclusion: Combining AMR and LVEF substantially refines 1-year prognostic risk stratification in STEMI patients. This approach uncovers a critical “pathophysiological decoupling” where isolated microvascular injury confers a hazard comparable to systolic impairment, supporting the transition toward more individualized post-STEMI management .
- Open Access
- 11 October 2025
- Published by Springer Nature in Aging Clinical and Experimental Research
- Vol. 37 (1) , 1-9
Dynapenic abdominal obesity and the risk of cardiovascular diseases: findings from the China Health and Retirement Longitudinal Study
Background Dynapenic abdominal obesity (DAO) is a health indicator associating with aging-related disease in older adults. However, no research has clarified the impact of DAO on cardiovascular diseases (CVD). We aim to investigate the distribution of DAO status and its association with subsequent CVD in middle-aged and older adults. Methods Data were derived from 2011 to 2018 in China Health and Retirement Longitudinal Study. The participants were classified as dynapenic abdominal obesity (D/AO), dynapenic non-abdominal obesity (D/NAO), non-dynapenic abdominal obesity (ND/AO) and non-dynapenic non-abdominal obesity (ND/NAO) based on waist circumference (≥ 90 cm for men or ≥ 85 cm for women) and handgrip strength (P = 0.044). Conclusions D/AO and ND/AO were both associated with higher risk of CVD among middle-aged and older adults, which was more pronounced in people younger than 65 years old. The presence of dynapenia further increased the risk of CVD in individuals with AO.
- 11 October 2025
- Published by Springer Nature in Aging Clinical and Experimental Research
- Vol. 37 (1) , 1-9
Open AccessDynapenic abdominal obesity and the risk of cardiovascular diseases: findings from the China Health and Retirement Longitudinal Study
Background Dynapenic abdominal obesity (DAO) is a health indicator associating with aging-related disease in older adults. However, no research has clarified the impact of DAO on cardiovascular diseases (CVD). We aim to investigate the distribution of DAO status and its association with subsequent CVD in middle-aged and older adults. Methods Data were derived from 2011 to 2018 in China Health and Retirement Longitudinal Study. The participants were classified as dynapenic abdominal obesity (D/AO), dynapenic non-abdominal obesity (D/NAO), non-dynapenic abdominal obesity (ND/AO) and non-dynapenic non-abdominal obesity (ND/NAO) based on waist circumference (≥ 90 cm for men or ≥ 85 cm for women) and handgrip strength (P = 0.044). Conclusions D/AO and ND/AO were both associated with higher risk of CVD among middle-aged and older adults, which was more pronounced in people younger than 65 years old. The presence of dynapenia further increased the risk of CVD in individuals with AO.
- Open Access
- 20 December 2024
- Published by Springer Nature in Environmental Health
- Vol. 23 (1) , 1-11
Air pollution is linked to cognitive decline independent of hypersensitive C-reactive protein: insights from middle-aged and older Chinese
Long-term air pollution exposure and inflammation are considered to be associated with cognitive decline. However, whether air pollution exposure related cognitive decline is dependent on inflammation remains uncertain. The present study collected data from China Health and Retirement Longitudinal Study (CHARLS) at baseline in 2011, with a follow up period in 2015. Concentration of air pollutants (particles with diameters ≤ 1.0 μm [PM1], ≤ 2.5 μm [PM2.5], ≤ 10 μm [PM10], nitrogen dioxide [NO2] and ozone [O3]) were obtained from China High Air Pollutants (CHAP) dataset. Hypersensitive C-reactive protein (hs-CRP), a systemic inflammation marker, was measured in blood of subjects and cognitive function was assessed by standardized questionnaire. A total of 6434 participants were included in the study. Lower exposure to PM2.5, PM1, PM10 and NO2 were associated with mitigated cognitive decline. The odds ratios (ORs) for air pollutants changes and cognitive decline and 95% confidence intervals (CIs) were as follows: PM2.5-0.934(0.925, 0.943), PM1- 0.945 (0.935,0.955), PM10-0.977(0.972,0.982) and NO2-0.962(0.950,0.975), respectively. Hs-CRP showed no significant correlation with cognitive decline or change in levels of air pollution. The interaction regression analyses, both unadjusted and adjusted, did not uncover any significant correlation between hs-CRP and air pollution with respect to cognitive decline. Bootstrap test exhibited no significant mediating effect of hs-CRP on the relationship between any air pollutants and cognitive decline, the indirect effects of hs-CRP in conjunction with exposure to different air pollutants were all found to be non-significant, with the following bootstrap CIs and p-values: PM2.5-1.000([1.000,1.000], P = 0.480),PM1-1.000([1.000,1.000], P = 0.230),PM10-1.000([1.000,1.000], P = 0.650), O3-1.000([1.000,1.000], P = 0.470), ΔNO2-1.000([1.000,1.000], P = 0.830) . Ambient air pollution exposure was linked to cognitive decline independent of hs-CRP level.
- 20 December 2024
- Published by Springer Nature in Environmental Health
- Vol. 23 (1) , 1-11
Open AccessAir pollution is linked to cognitive decline independent of hypersensitive C-reactive protein: insights from middle-aged and older Chinese
Long-term air pollution exposure and inflammation are considered to be associated with cognitive decline. However, whether air pollution exposure related cognitive decline is dependent on inflammation remains uncertain. The present study collected data from China Health and Retirement Longitudinal Study (CHARLS) at baseline in 2011, with a follow up period in 2015. Concentration of air pollutants (particles with diameters ≤ 1.0 μm [PM1], ≤ 2.5 μm [PM2.5], ≤ 10 μm [PM10], nitrogen dioxide [NO2] and ozone [O3]) were obtained from China High Air Pollutants (CHAP) dataset. Hypersensitive C-reactive protein (hs-CRP), a systemic inflammation marker, was measured in blood of subjects and cognitive function was assessed by standardized questionnaire. A total of 6434 participants were included in the study. Lower exposure to PM2.5, PM1, PM10 and NO2 were associated with mitigated cognitive decline. The odds ratios (ORs) for air pollutants changes and cognitive decline and 95% confidence intervals (CIs) were as follows: PM2.5-0.934(0.925, 0.943), PM1- 0.945 (0.935,0.955), PM10-0.977(0.972,0.982) and NO2-0.962(0.950,0.975), respectively. Hs-CRP showed no significant correlation with cognitive decline or change in levels of air pollution. The interaction regression analyses, both unadjusted and adjusted, did not uncover any significant correlation between hs-CRP and air pollution with respect to cognitive decline. Bootstrap test exhibited no significant mediating effect of hs-CRP on the relationship between any air pollutants and cognitive decline, the indirect effects of hs-CRP in conjunction with exposure to different air pollutants were all found to be non-significant, with the following bootstrap CIs and p-values: PM2.5-1.000([1.000,1.000], P = 0.480),PM1-1.000([1.000,1.000], P = 0.230),PM10-1.000([1.000,1.000], P = 0.650), O3-1.000([1.000,1.000], P = 0.470), ΔNO2-1.000([1.000,1.000], P = 0.830) . Ambient air pollution exposure was linked to cognitive decline independent of hs-CRP level.
- Open Access
- 1 November 2024
- Published by AME Publishing Company in Journal of Thoracic Disease
- Vol. 16 (11) , 7771-7786
The influence between plaque rupture and non-plaque rupture on clinical outcomes in patients with ST-segment elevation myocardial infarction after primary percutaneous coronary intervention: a prospective cohort study
Background: Coronary atherosclerosis can lead to acute clinical events upon atherosclerotic plaque rupture (PR) or erosion and arterial thrombus formation. Identifying the effect of distinct plaque characteristics on clinical outcomes in patients with ST-segment elevation myocardial infarction (STEMI) is critical for clinical therapy. Our goal was to ascertain the correlation between clinical outcome, long-term prognosis, and morphological plaque characteristics in STEMI. Methods: The data used in this prospective cohort research came from a prior multicenter prospective cohort study (ChiCTR1800019923). One hundred and thirteen consecutive STEMI patients were involved in our cohort study. Patients with STEMI who received primary percutaneous coronary intervention (pPCI) within 24 hours of symptom onset were included in the study and divided into two groups according to plaque characteristics derived from intravascular ultrasound (IVUS): a PR group and a non-PR group. The primary outcome was the incidence of no reflow or slow flow, the secondary outcome was major adverse cardiac events (MACEs) at 1-year follow-up. Results: This study enrolled 113 consecutive patients with STEMI [mean age 56 (range, 49–65.5) years; males 90.27%]. Of the 113 patients, PR was found in 93 (82.3%), while non-PR was found in 20 (17.7%). The PR group had a higher rates of plaque eccentricity index (64.28%±22.69% vs. 60.08%±15.54%; P=0.045), higher rates of lipid pool-like images (62.37% vs. 30.00%; P=0.008), and higher rates of tissue prolapse (22.95% vs. 13.33%; P=0.01). Compared with that in the non-PR group, the incidence of no reflow or slow flow was higher in the PR group after pPCI (26.88% vs. 5.00%; P=0.04). Multivariable logistic regression showed that PR [odds ratio (OR) =8.188; 95% confidence interval (CI): 1.020–65.734; P=0.048] was an independent predictor of no reflow or slow flow. Survival analysis revealed no significant differences in MACE incidence between the two groups at 1-year follow-up (7.61% vs. 10.00%; P=0.66). Furthermore, 29 patients with PR were treated without stenting, most of them were free of MACEs (27/29). MACE between subgroups of stenting and non-stenting had no significant differences (7.94% vs. 6.90%; P=0.86) in the PR group. Conclusions: In comparison to patients with non-PR, PR were not associated with the risk of recurrent myocardial infarction (MI), revascularization, heart failure, or cardiac death at 1-year follow-up, while associated with an increased incidence of no reflow or slow flow during pPCI. This observation would be considered while risk stratification and dealing with patients who have STEMI. Most patients with PR who were treated without stenting were MACE free. Further research should be conducted to determine whether interventional treatment without stenting is feasible for patients with STEMI and PR.
- 1 November 2024
- Published by AME Publishing Company in Journal of Thoracic Disease
- Vol. 16 (11) , 7771-7786
Open AccessThe influence between plaque rupture and non-plaque rupture on clinical outcomes in patients with ST-segment elevation myocardial infarction after primary percutaneous coronary intervention: a prospective cohort study
Background: Coronary atherosclerosis can lead to acute clinical events upon atherosclerotic plaque rupture (PR) or erosion and arterial thrombus formation. Identifying the effect of distinct plaque characteristics on clinical outcomes in patients with ST-segment elevation myocardial infarction (STEMI) is critical for clinical therapy. Our goal was to ascertain the correlation between clinical outcome, long-term prognosis, and morphological plaque characteristics in STEMI. Methods: The data used in this prospective cohort research came from a prior multicenter prospective cohort study (ChiCTR1800019923). One hundred and thirteen consecutive STEMI patients were involved in our cohort study. Patients with STEMI who received primary percutaneous coronary intervention (pPCI) within 24 hours of symptom onset were included in the study and divided into two groups according to plaque characteristics derived from intravascular ultrasound (IVUS): a PR group and a non-PR group. The primary outcome was the incidence of no reflow or slow flow, the secondary outcome was major adverse cardiac events (MACEs) at 1-year follow-up. Results: This study enrolled 113 consecutive patients with STEMI [mean age 56 (range, 49–65.5) years; males 90.27%]. Of the 113 patients, PR was found in 93 (82.3%), while non-PR was found in 20 (17.7%). The PR group had a higher rates of plaque eccentricity index (64.28%±22.69% vs. 60.08%±15.54%; P=0.045), higher rates of lipid pool-like images (62.37% vs. 30.00%; P=0.008), and higher rates of tissue prolapse (22.95% vs. 13.33%; P=0.01). Compared with that in the non-PR group, the incidence of no reflow or slow flow was higher in the PR group after pPCI (26.88% vs. 5.00%; P=0.04). Multivariable logistic regression showed that PR [odds ratio (OR) =8.188; 95% confidence interval (CI): 1.020–65.734; P=0.048] was an independent predictor of no reflow or slow flow. Survival analysis revealed no significant differences in MACE incidence between the two groups at 1-year follow-up (7.61% vs. 10.00%; P=0.66). Furthermore, 29 patients with PR were treated without stenting, most of them were free of MACEs (27/29). MACE between subgroups of stenting and non-stenting had no significant differences (7.94% vs. 6.90%; P=0.86) in the PR group. Conclusions: In comparison to patients with non-PR, PR were not associated with the risk of recurrent myocardial infarction (MI), revascularization, heart failure, or cardiac death at 1-year follow-up, while associated with an increased incidence of no reflow or slow flow during pPCI. This observation would be considered while risk stratification and dealing with patients who have STEMI. Most patients with PR who were treated without stenting were MACE free. Further research should be conducted to determine whether interventional treatment without stenting is feasible for patients with STEMI and PR.
- 11 October 2024
- Published by Elsevier in Journal of the American Medical Directors Association
- Vol. 25 (12) , 105301
Associations of Regular Internet Usage with All-Cause and Cause-Specific Mortality: A Prospective Cohort Study
- 11 October 2024
- Published by Elsevier in Journal of the American Medical Directors Association
- Vol. 25 (12) , 105301
Associations of Regular Internet Usage with All-Cause and Cause-Specific Mortality: A Prospective Cohort Study
- Open Access
- 7 September 2024
- Published by Elsevier in The Journal of nutrition, health and aging
- Vol. 28 (10) , 100353
Sarcopenic obesity is associated with cardiometabolic multimorbidity in Chinese middle-aged and older adults: a cross-sectional and longitudinal study
- 7 September 2024
- Published by Elsevier in The Journal of nutrition, health and aging
- Vol. 28 (10) , 100353
Open AccessSarcopenic obesity is associated with cardiometabolic multimorbidity in Chinese middle-aged and older adults: a cross-sectional and longitudinal study
- Open Access
- 14 August 2024
- Published by Springer Nature in BMC Cardiovascular Disorders
- Vol. 24 (1) , 1-10
Smoking paradox in coronary function and structure of acute ST-segment elevation myocardial infarction patients treated with primary percutaneous coronary intervention
The Smoking paradox has generated inconsistent findings concerning the clinical prognosis of acute ST-segment elevation myocardial infarction (STEMI) patients, while providing limited insights into coronary anatomy and function which are crucial prognostic factors. Therefore, this study aimed to further investigate the existence of smoking paradox in coronary anatomy and function. This study divided STEMI patients into smokers and non-smokers. Quantitative coronary angiography, angiography‑derived microcirculatory resistance (AMR) and quantitative flow ratio (QFR) were utilized to analyze coronary anatomy and function. These parameters were compared using multivariable analysis and propensity score matching. The clinical outcomes were evaluated using Kaplan-Meier curve and Cox regression. The study included 1258 patients, with 730 in non-smoker group and 528 in smoker group. Smokers were significantly younger, predominantly male, and had fewer comorbidities. Without adjusting for confounders, smokers exhibited larger lumen diameter [2.03(1.45–2.57) vs. 1.90(1.37–2.49), P = 0.033] and lower AMR [244(212–288) vs. 260(218–301), P = 0.006]. After matching and multivariate adjustment, smokers exhibited inversely smaller lumen diameter [1.97(1.38–2.50) vs. 2.15(1.63–2.60), P = 0.002] and higher incidence of coronary microvascular dysfunction [233(53.9%) vs. 190(43.6%), P = 0.002], but showed similar AMR and clinical outcomes compared to non-smokers. There was no difference in QFR between two groups. Smoking among STEMI patients undergoing pPCI was associated with smaller lumen diameter and higher occurrence of coronary microvascular dysfunction, although it had no further impact on clinical prognosis. The smoking paradox observed in coronary anatomy or function may be explained by younger age, gender, and lower prevalence of comorbidities.
- 14 August 2024
- Published by Springer Nature in BMC Cardiovascular Disorders
- Vol. 24 (1) , 1-10
Open AccessSmoking paradox in coronary function and structure of acute ST-segment elevation myocardial infarction patients treated with primary percutaneous coronary intervention
The Smoking paradox has generated inconsistent findings concerning the clinical prognosis of acute ST-segment elevation myocardial infarction (STEMI) patients, while providing limited insights into coronary anatomy and function which are crucial prognostic factors. Therefore, this study aimed to further investigate the existence of smoking paradox in coronary anatomy and function. This study divided STEMI patients into smokers and non-smokers. Quantitative coronary angiography, angiography‑derived microcirculatory resistance (AMR) and quantitative flow ratio (QFR) were utilized to analyze coronary anatomy and function. These parameters were compared using multivariable analysis and propensity score matching. The clinical outcomes were evaluated using Kaplan-Meier curve and Cox regression. The study included 1258 patients, with 730 in non-smoker group and 528 in smoker group. Smokers were significantly younger, predominantly male, and had fewer comorbidities. Without adjusting for confounders, smokers exhibited larger lumen diameter [2.03(1.45–2.57) vs. 1.90(1.37–2.49), P = 0.033] and lower AMR [244(212–288) vs. 260(218–301), P = 0.006]. After matching and multivariate adjustment, smokers exhibited inversely smaller lumen diameter [1.97(1.38–2.50) vs. 2.15(1.63–2.60), P = 0.002] and higher incidence of coronary microvascular dysfunction [233(53.9%) vs. 190(43.6%), P = 0.002], but showed similar AMR and clinical outcomes compared to non-smokers. There was no difference in QFR between two groups. Smoking among STEMI patients undergoing pPCI was associated with smaller lumen diameter and higher occurrence of coronary microvascular dysfunction, although it had no further impact on clinical prognosis. The smoking paradox observed in coronary anatomy or function may be explained by younger age, gender, and lower prevalence of comorbidities.
- Open Access
Association of Air Quality Improvement and Frailty Progression: A National Study across China
Accumulating evidence strongly suggests that exposure to ambient air pollution is linked with increased frailty. However, little is known about the effect of improved air quality on frailty progression. We aimed to investigate whether improvements in air quality (PM1, PM2.5, PM10, NO2, and O3) can alleviate frailty progression, particularly in the aftermath of implementation of the “Clean Air Action” policy in China. The study involved 12,891 participants with geocoded environmental data from the nationwide China Health and Retirement Longitudinal Study (CHARLS) during the period from May 2011 to August 2015. Multivariate logistic regression models were used to analyze the association of air pollution improvements and frailty progression. The protective effects were noted for PM1, PM2.5, PM10, and NO2 indices, with an aOR (adjusted odds ratio) ranging from 0.72 to 0.79. Air quality improvement in PM1, PM2.5, PM10, and NO2 could alleviate the progression of frailty. The study is the first to examine the association between the improvement of air quality and the progression of frailty, setting a precedent for the importance of a nationwide clean air policy and its impact on healthy ageing.
Open AccessAssociation of Air Quality Improvement and Frailty Progression: A National Study across China
Accumulating evidence strongly suggests that exposure to ambient air pollution is linked with increased frailty. However, little is known about the effect of improved air quality on frailty progression. We aimed to investigate whether improvements in air quality (PM1, PM2.5, PM10, NO2, and O3) can alleviate frailty progression, particularly in the aftermath of implementation of the “Clean Air Action” policy in China. The study involved 12,891 participants with geocoded environmental data from the nationwide China Health and Retirement Longitudinal Study (CHARLS) during the period from May 2011 to August 2015. Multivariate logistic regression models were used to analyze the association of air pollution improvements and frailty progression. The protective effects were noted for PM1, PM2.5, PM10, and NO2 indices, with an aOR (adjusted odds ratio) ranging from 0.72 to 0.79. Air quality improvement in PM1, PM2.5, PM10, and NO2 could alleviate the progression of frailty. The study is the first to examine the association between the improvement of air quality and the progression of frailty, setting a precedent for the importance of a nationwide clean air policy and its impact on healthy ageing.
- Open Access
- 10 June 2024
- Published by Taylor & Francis in Renal Failure
- Vol. 46 (2) , 2361094
Remnant cholesterol, preinflammatory state and chronic kidney disease: association and mediation analyses
Blood lipid management is a key approach in the prevention of chronic kidney disease (CKD). Remnant cholesterol (RC) plays an important role in the development of multiple diseases via chronic inflammation. The aim of our study was to determine the relationship between RC and CKD and explore the role of inflammation in this relationship. The 7696 subjects from the Chinese Health and Nutrition Survey were divided into four subgroups according to the quartile of RC. The estimated glomerular filtration rate was calculated using the CKD Epidemiology Collaboration equation. Fasting RC was calculated as total cholesterol minus low-density lipoprotein cholesterol and high-density lipoprotein cholesterol. Logistic regression analysis was employed to evaluate the relationships between RC and CKD. Mediation analysis was undertaken to identify potential mediators of high-sensitivity C-reactive protein (hs-CRP) and white blood cells (WBCs). Of all participants, the mean age was 51 years, and the male accounted for 47.8%. The multivariable-adjusted odds ratios (95% CIs) for the highest versus lowest quartile of remnant cholesterol were 1.40 (1.10-1.78, p for trend = 0.006) for CKD. RC and preinflammatory markers have combined effect on CKD. The preinflammatory state, presented by increased hs-CRP or WBCs, partially mediated the association between RC and CKD with proportion of 10.14% (p = 0.002) and 11.65% (p = 0.012), respectively. In conclusion, this study suggested a positive relationship between RC and CKD, which was partially mediated by preinflammatory state. These findings highlight the importance of RC and inflammation in renal dysfunction.IMPACT STATEMENTWhat is already known on this subject?: Dyslipidemia plays an important role in the development of chronic kidney disease (CKD). Remnant cholesterol (RC), as a triglyceride-rich particle, can contribute to target organ damage, primarily through inflammatory pathways. However, the relationship between RC and CKD in the community-dwelling population, particularly the role of inflammation, is not yet fully understood.What do the results of this study add?: This study shows that RC was significantly associated with CKD. RC and preinflammatory status exhibit a combined effect on CKD. Preinflammatory state, presented by increased high-sensitivity C-reactive protein or white blood cells, partially mediated the association between RC and CKD.What are the implications of these findings for clinical practice and/or further research?: The study provides us with a better understanding of the role of RC and inflammation in kidney dysfunction and raises the awareness of RC in the management of CKD.
- 10 June 2024
- Published by Taylor & Francis in Renal Failure
- Vol. 46 (2) , 2361094
Open AccessRemnant cholesterol, preinflammatory state and chronic kidney disease: association and mediation analyses
Blood lipid management is a key approach in the prevention of chronic kidney disease (CKD). Remnant cholesterol (RC) plays an important role in the development of multiple diseases via chronic inflammation. The aim of our study was to determine the relationship between RC and CKD and explore the role of inflammation in this relationship. The 7696 subjects from the Chinese Health and Nutrition Survey were divided into four subgroups according to the quartile of RC. The estimated glomerular filtration rate was calculated using the CKD Epidemiology Collaboration equation. Fasting RC was calculated as total cholesterol minus low-density lipoprotein cholesterol and high-density lipoprotein cholesterol. Logistic regression analysis was employed to evaluate the relationships between RC and CKD. Mediation analysis was undertaken to identify potential mediators of high-sensitivity C-reactive protein (hs-CRP) and white blood cells (WBCs). Of all participants, the mean age was 51 years, and the male accounted for 47.8%. The multivariable-adjusted odds ratios (95% CIs) for the highest versus lowest quartile of remnant cholesterol were 1.40 (1.10-1.78, p for trend = 0.006) for CKD. RC and preinflammatory markers have combined effect on CKD. The preinflammatory state, presented by increased hs-CRP or WBCs, partially mediated the association between RC and CKD with proportion of 10.14% (p = 0.002) and 11.65% (p = 0.012), respectively. In conclusion, this study suggested a positive relationship between RC and CKD, which was partially mediated by preinflammatory state. These findings highlight the importance of RC and inflammation in renal dysfunction.IMPACT STATEMENTWhat is already known on this subject?: Dyslipidemia plays an important role in the development of chronic kidney disease (CKD). Remnant cholesterol (RC), as a triglyceride-rich particle, can contribute to target organ damage, primarily through inflammatory pathways. However, the relationship between RC and CKD in the community-dwelling population, particularly the role of inflammation, is not yet fully understood.What do the results of this study add?: This study shows that RC was significantly associated with CKD. RC and preinflammatory status exhibit a combined effect on CKD. Preinflammatory state, presented by increased high-sensitivity C-reactive protein or white blood cells, partially mediated the association between RC and CKD.What are the implications of these findings for clinical practice and/or further research?: The study provides us with a better understanding of the role of RC and inflammation in kidney dysfunction and raises the awareness of RC in the management of CKD.